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Plaque Excision Is An Effective Treatment Option for Diabetic Patients:
Results from the DEFINITIVE LE Study
Lawrence Garcia1, Thomas Zeller2, James McKinsey3
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Freiburg-Bad Krozingen, Bad Krozingen, Germany, 3Columbia/Cornell New York
Presbyterian Hospital System, New York, New York
Background: Diabetes has been associated with an increased risk of peripheral arterial
disease (PAD) and worse outcomes following treatment. The DEFINITIVE LE study was
a global study that assessed the effectiveness of plaque excision using the SilverHawk®
and TurboHawkTM systems (Covidien/ev3, Plymouth, MN) for endovascular treatment
of PAD in femoropopliteal and tibial-peroneal arteries.
Methods: 800 patients with a total of 1023 infrainguinal lesions were enrolled in
DEFINITIVE LE and underwent revascularization with plaque excision. Follow-up
assessments occurred at pre-discharge, 30 days, 3 months (for patients with RCC 5 or 6),
6 months and 1 year post-procedure. Endpoints were assessed by independent angio-
graphic and duplex core laboratories and adverse events were adjudicated by a Clinical
Events Committee. The primary endpoint for claudicants was primary patency (defined
using both PSVR  2.4 and PSVR  3.5and estimated by Kaplan-Meier methods).
Secondary assessments included change in Rutherford Clinical Category, ankle-brachial
index, the Walking Impact Questionnaire, EQ-5D quality of life and adverse events.
Results: Preliminary results are shown pending database closure and monitoring; final
results will be presented at TCT 2012. The study enrolled 600 subjects (745 lesions) with
claudication, 46.7% (280/600) of which had diabetes. Subjects with diabetes differed
significantly from those without diabetes in multiple baseline characteristics, but acute and
1-year outcomes were largely similar. Demographics, lesion characteristics and outcomes
are shown below.
Characteristic/
Outcome
Diabetics
(n280,
345 lesions)
Non-diabetics
(n320,
400 lesions) P-value
Age (yrs) 67.6 9.7 71.1 10.8 0.001
Female 41.4% 46.3% 0.24
Caucasian 63.2% 79.4% 0.001
History and risk
factors
Hypertension 95.0% 88.8% 0.007
CHF 18.6% 8.4% 0.001
Renal insufficiency 22.9% 11.3% 0.001
Myocardial
infarction
22.9% 14.7% 0.011
Current or former
smoker
47.1% 59.4% 0.003
Mean lesion length
(cm)
7.6 5.3 7.5 5.3 0.84
Baseline diameter
stenosis
71.9% 17.1% 73.5% 19.0% 0.25
Post-plaque excision
stenosis
23.8% 12.3% 23.9% 13.7% 0.89
Device success 78.4% 74.0% 0.17
1-year primary
patency (PSVR 2.4)
77.2% 74.0% 0.46
1-year primary
patency (PSVR 3.5)
80.9% 79.9% 0.64
Conclusions: Plaque excision is an effective treatment modality for patients with
diabetes. It may be particularly appealing in diabetic patients because it removes the
plaque, opens the lumen and preserves future treatment options in this progressive disease.
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Background: Diabetes mellitus is associated with accelerated progression of coronary
artery disease and impaired outcome after percutaneous coronary interventions. The aim
of this study was to evaluate angiographic and clinical outcomes after the implantation of
everolimus-eluting Xience V/Promus (EES) and sirolimus-eluting Cypher Select	 (SES)
stents in patients with diabetes.
Methods: The study was a Danish multicenter, open-label, randomized trial. We
randomized 213 patients with diabetes and coronary artery disease to EES (n108) or
SES (n105) implantation. Angiographic follow-up was performed after 10 months. All
patients were followed clinically for 18 months. The primary end point was angiographic
in-stent late luminal loss. Secondary end points included angiographic restenosis rate, the
need for target lesion revascularization (TLR) and major adverse cardiac events (MACE).
Results: At 10-month angiographic follow-up, in-stent late lumen loss was 0.20  0.53
mm and 0.11  0.49 mm (p0.28), and angiographic restenosis rate was 3.8 % and 5.2
% (p0.72) in the EES and SES groups, respectively. At 18-month clinical follow-up,
MACE events had occurred in 15 (14%) patients in the EES group and 18 (17%) patients
in SES group (p0.53), with TLR performed in 5 (5%) and 8 (8%) patients in the two
groups (p0.37).
Conclusions: Stent implantation with EES or SES is associated with similar angio-
graphic and clinical outcome in patients with diabetes mellitus and coronary artery
disease.
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Circumferential Therapeutic Ultrasound for the Treatment of Resistant
Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)
Peter Neuzil1, Jan Petru1, Dagmar Vondrakova1, Karel Kopriva1,
Milan Chovanec1, Lucie Sediva1, Jacob Koruth2, Srinivas Dukkipati2,
Andre d’Avila2, Vivek Reddy2
1Homolka Hospital, Prague, Czech Republic, 2Mt. Sinai Medical Center, New
York, NY
Background: Renal artery sympathetic denervation using radiofrequency (RF) energy
has been shown to reduce blood pressure in patients with resistant hypertension. However,
energy forms like RF which rely on conductive heating cause transmural arterial damage
before achieving denervation of the periarterial sympathetic nerve plexus. In vitro and
pre-clinical testing has demonstrated that therapeutic ultrasound energy can induce
differential injury to the nerve fibers while sparing the arterial wall. We now report on the
preliminary results of a first-in-human feasibility trial with this novel therapeutic
ultrasound system in patients with refractory hypertension.
Methods: Ten patients with a history of drug-resistant hypertension were enrolled
in the SOUND-ITV study. The ultrasound catheter (Sound Interventions, Inc,
Stony Brook, NY), incorporating a cylindrical transducer encased within a novel
non-cylindrical, non-occlusive balloon was advanced into the renal arteries
through a sheath. Ultrasound energy was delivered in a circumferential manner to
both renal arteries; an average of 1.8 applications were delivered to each renal
artery. Energy delivery time was less than 2 minutes per patient. Renal artery
diameters ranged from 5.0-8.6 mm.
Results: Patients with a baseline systolic office BP  160 mmHg demonstrated a
significant reduction in the office BP at 1 month follow-up: the average BP drop of -31/-10
mmHg. All patients tolerated the procedures well with deep sedation. There was no device
or energy-related spasm. Acutely and through follow-up, there were no device or
procedure related complications. Arteries were assessed post procedure by angiography
(n10) and IVUS (n7). No changes in arterial size were observed.
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Conclusions: This first-in-man experience demonstrates the ability of circumfer-
ential intravascular therapeutic ultrasound to significantly improve blood pressure
in patients with resistant hypertension. Longer term follow-up is necessary to
confirm these results.
TCT-357
Trends and Outcomes Of Primary Percutaneous Coronary Intervention
(PPCI) In Octogenarians Including A Comparison Between Radial and
Femoral PPCI Strategies: A Single Centre Experience
Parisha Khan1, Pitt Lim2
1St George’s Hospital, London, London, 2St Georges’ Hospital, London, London,
London
Background: An ageing UK population in combination with a preference for
treating acute myocardial infarction (AMI) with PPCI has lead to an increase in
the number of octogenarians treated with PPCI. The aim of the study was to
provide an insight into clinical and procedural characteristics of octogenarian
PPCI including in-hospital outcomes, mortality and a comparison between radial
and femoral PPCI strategies.
Methods: From April 2007 to August 2011, consecutive octogenarians treated with PPCI
at our institute were retrospectively included in the study cohort. Baseline characteristics,
procedural results and in-hospital outcomes were analysed. A matched pair analysis was
performed comparing 37 octogenarians with 37 patients  80 years treated with PPCI in
2010. Finally, an intra-age analysis was performed comparing outcomes between radial
and femoral PPCI procedures. All cause mortality was taken at end points of in-hospital,
30 days and 1 year.
Results: 177 octogenarians were treated with PPCI during the study period. The annual
proportion of octogenarians increased significantly to as many as 1 in 5 cases (7.0% to
20.0%, p0.05). Overall in hospital mortality was 14.7% (n26) with the highest
mortality in patients 95 years (33.3%). Compared to patients 80 years, octogenarians
had significantly longer median procedural times (58 mins vs 43 mins, p 0.05), median
discharge times (5 days vs 3 days, p  0.05) and more post procedural complications. In
comparison to femoral PPCI, radial PPCI by high volume operators was associated with
fewer vascular complications and shorter discharge times. Radial PPCI was associated
with significantly lower mortality at 1 year than femoral PPCI, 11.1% (n4) vs 28.5%
(n39) respectively (p0.05).
Conclusions: The proportion of octogenarian PPCI patients has increased. This is a high
risk population with longer procedures, more post procedural complications and longer
discharge times compared to younger patients. The study demonstrated that radial PPCI
by high volume operators resulted in fewer vascular complications, shorter discharge
times and lower mortality at 1 year compared to femoral PPCI, consistent with recently
published randomised trials.
TCT-358
Food And Drug Administration Approved Cardiovascular Medical Devices: A
Ten Year Review Of The Participation Of Women And Ethnic Subgroups
Beverly Gallauresi1, Dipali Dave1
1FDA, Silver Spring, MD
Background: For some diseases, different demographic subgroups may have different
prevalence, diagnosis, disease progression and treatment outcomes. Although cardiovas-
cular disease (CVD) is the number one killer for women and men, women have
historically been underrepresented in cardiovascular clinical trials (CVCTs). To accu-
rately assess sex differences in the safety and efficacy of medical devices, it is necessary
to have representation of both sexes in clinical trials to allow for sex specific analysis. The
purpose of this study was to assess the participation of women and ethnic subgroups in
CVCTs submitted in support of medical device premarket applications (PMAs) approved
by the US FDA from 2002 to 2011.
Methods: All CVCTs in approved PMAs between 2002-2011 were included in the study.
Descriptive analyses of the study participants’ ethnicity and sex were done. Demographic
data from PMAs were analyzed in 12 month intervals to detect any trends in the
participation of women and ethic subgroups.
Results: One hundred cardiovascular PMAs were approved between 2002 and 2011. One
PMA was excluded from review as it addressed a pediatric population. Women’s
participation in PMA CVCTs was: 2002 (31.1%), 2003 (35.8%), 2004 (27.9%), 2005
(36.3%), 2006 (27.1%), 2007 (38.5%), 2008 (34%), 2009 (32.8%), 2010 (26.9%) and
2011 (39.6 %). The average women’s percentage of participation in PMAs for this
10-year period was 32.9%. Twenty-one PMAs included ethnicity data with the following
average participation rates: White (85.9 %), African American (8.3%), Hispanic (2.9%),
Asian (1.3 %), Native Hawaiian (‹1%), Native American (‹1%), Other (1.3%).
Conclusions: This ten year review indicates that there is no recognizable trend and that
women’s participation in CVCTs in approved PMAs ranged from 26.9 to 39.6% over the
ten year period. There is a need to increase reporting of data by ethnicity. An increase in
the numbers of ethnic subgroups participating in CVCTs would allow for outcomes
analysis in these populations.
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Percutaneous Coronary Intervention In Octogenarians: Single High Volume
United Kingdom Center Experience
Refai Showkathali1, Ed Boston-Griffiths1, Hetalkumar Patel1, Anil Ramoutar1,
John Davies1, Alamgir Kabir1, Reto Gamma1, Jeremy Sayer1, Gerald Clesham1,
Paul Kelly1, Rajesh Aggarwal1
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Background: Octogenarians constitute an increasing proportion of patients referred for
percutaneous coronary intervention (PCI) for stable angina and acute coronary syndromes
(ACS). However, there are limited outcome data for PCI in this group. We evaluated the
outcome of PCI in patients aged  80 yrs and compared them with younger patients
treated in our centre.
Methods: We analysed all patients aged  80 yrs who underwent PCI in our unit
between Sept 2009 and Dec 2010. We defined major bleeding as the need for at-least one
unit of red cell transfusion.
Results: Of the 2931 patients who underwent PCI in our unit during the study period, 401
(13.7%) patients were80 yrs of age. Of these, 163 (40.6%) had primary PCI (PPCI) for
STEMI, 120 (29.9%) had PCI for non ST elevation ACS (NSTEACS) and 118 (29.4%)
had PCI for stable angina. The demographic, procedural data and mortality of octoge-
narians are compared with younger patients (Table 1). The total 30-day mortality for
patients aged  80 yrs was 8.7% compared with 1.3% for those aged 80 yrs
(P0.0001). This highly significant mortality difference was almost entirely to a fivefold
higher mortality in patients aged  80 yrs (20.2%) undergoing primary PCI (PPCI) for
STEMI compared with younger patients (3.9%). (Table 1) In Octogenarians, non fatal MI,
non fatal CVA and major bleeding occurred in 1.5%, 0.5% and 3.2% of all PCI patients,
2.5%, 0.6% and 3.1% of PPCI patients, 1.7%, 0% and 5% of patients undergoing PCI for
NSTE-ACS, 0%, 0.85% and 0.85% of patients undergoing PCI for stable angina
respectively.
n (%)
> 80 yrs
n401
<80 yrs
n 2530 p value
Age (meanSD) 84 4 63 10.2 0.0001
Male 225 (56.1) 1917 (75.8) 0.0001
PPCI for STEMI 163 (40.6) 765 (30.2) 0.0001
PCI for NSTE-ACS 120 (29.9) 739 (29.2) 0.77
PCI for stable angina 118 (29.4) 1026 (40.6) 0.0001
Diabetes 70 (17.5) 402 (15.9) 0.38
Cardiogenic shock 15 (3.7) 54 (2.1) 0.07
Previous MI 135 (33.7) 599 (23.7) 0.0001
Previous CABG 33 (8.2) 158 (6.2) 0.13
Previous PCI 55 (13.7) 488 (19.3) 0.007
No of stents (meanSD) 1.55 1.1 1.45 0.9 0.05
LMS involvement (75%
stenosis)
14 (3.5) 44 (1.7) 0.03
Single vessel PCI 303 (75.6) 2073 (81.9) 0.003
DES usage (at least 1 DES) 196 (48.9) 1667 (65.9) 0.0001
In-hospital mortality 25 (6.2) 24 (0.9) 0.0001
Total 30-day mortality 35 (8.7) 34 (1.3) 0.0001
30-day mortality in PPCI 33 (20.2) 30 (3.9) 0.0001
30-day mortality in NSTE-ACS 2 (1.7) 3 (0.4) 0.15
30-day mortality in Stable
angina
0 1 (0.1) 1
Conclusions: In this consecutive series from a high volume tertiary centre,
patients aged  80 yrs undergoing PCI have 30-day mortality rates similar to
younger patients treated for stable angina or NSTEACS. Further studies are
required to refine treatment strategies in unselected patients aged  80 yrs
undergoing PPCI for STEMI.
TCT-360
Is there a Different of Management for ST-Elevation Myocardial Infarction
regarding Gender? Myth or Reality? Data from a Prospective Registry of
5000 Patients
Marc Bedossa1, Guillaume Leurent1, Isabelle Coudert2, Philippe Druelles3,
Jean Philippe Hacot4, Benoit Moquet5, Dominique Boulmier1, Herve le Breton1
1Department of Cardiology, Rennes, France, 2Emergency Care Unit, Rennes,
France, 3Clinique St Laurent, Rennes, France, 4CH Lorient, Lorient, France, 5CH
St Brieuc, St Brieuc, France
Background: A few studies suggest a difference in management of ST elevation
Myocardial Infarction (STEMI) by gender. We will evaluated this point and the
implications from a prospective registry of 5000 patients.
Methods: We analyzed data collected in a 6 years period in the “Observatoire
Régional Breton sur l’Infarctus (ORBI)”, a prospective registry of STEMI patients
admitted within 24 h of symptom onset to an interventional cardiology centre in
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AM www.jacc.tctabstracts2012.com
B102 JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Gender, Age, and Other Demographic Considerations
P
O
ST
E
R
S
